ClearPoint Neuro price target raised to $17 from $15 at Lake Street

Lake Street raised the firm’s price target on ClearPoint Neuro (CLPT) to $17 from $15 and keeps a Buy rating on the shares. Q3 outperformance was driven by another quarter of broad-business strength, says the firm, which tells investors that “the business has significant growth momentum, expectations are in check, profitability is improving, and the balance sheet is solid.”